Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Gustafsson

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Thrombosis Research|January 15, 1997
In vitro effects of inogatran, a selective low molecular weight thrombin inhibitorA C Teger-Nilsson, R Bylund, D Gustafsson, et al.
Basic Research in Cardiology|May 1, 1991
Superoxide dismutase and catalase do not improve recovery of regional myocardial contractile function when given at the time of reperfusion after reversible regional ischemia in anesthetized dogsJ A Björkman, I Sutherland, D Gustafsson, et al.
Clinical and Experimental Immunology|October 7, 2017
Whole genome microarray expression analysis in blood identifies pathways linked to signs and symptoms of a patient with hypercalprotectinaemia and hyperzincaemiaH S Isaksson, S A Farkas, P Müller, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 1, 1993
A new rat model of arterial thrombosis with a platelet-rich head and an erythrocyte-rich tail: thrombolysis experiments with specific thrombin inhibitionS Lenfors, L Marberg, S Wikström, et al.
Journal of Thrombosis and Haemostasis : JTH|July 23, 2003
A randomized, controlled, dose-guiding study of the oral direct thrombin inhibitor ximelagatran compared with standard therapy for the treatment of acute deep vein thrombosis: THRIVE IH Eriksson, K Wåhlander, D Gustafsson, et al.
Blood Pressure|May 1, 1992
Raised plasma concentrations of endothelin-1 and -3 in marmosets with acute aortic stenosis: no relation to the renin-angiotensin systemD Gustafsson, M Elg, T Hedner, et al.
Nature Nanotechnology|December 11, 2012
Fully gapped superconductivity in a nanometre-size YBa2Cu3O(7-δ) island enhanced by a magnetic fieldD Gustafsson, D Golubev, M Fogelström, et al.
American Heart Journal|July 1, 1988
The role of sympathetic activity in atherogenesis: effects of beta-blockadeB Ablad, J A Björkman, D Gustafsson, et al.
Journal of Cardiovascular Pharmacology|March 26, 1998
Melagatran, an oral active-site inhibitor of thrombin, prevents or delays formation of electrically induced occlusive thrombus in the canine coronary arteryJ L Mehta, L Chen, W W Nichols, et al.
Ultrasound in Medicine & Biology|January 1, 1992
Noninvasive measurement of diameter changes in the distal abdominal aorta in manT Länne, H Stale, H Bengtsson, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Thrombosis Research|January 15, 1997
In vitro effects of inogatran, a selective low molecular weight thrombin inhibitorA C Teger-Nilsson, R Bylund, D Gustafsson, et al.
Basic Research in Cardiology|May 1, 1991
Superoxide dismutase and catalase do not improve recovery of regional myocardial contractile function when given at the time of reperfusion after reversible regional ischemia in anesthetized dogsJ A Björkman, I Sutherland, D Gustafsson, et al.
Clinical and Experimental Immunology|October 7, 2017
Whole genome microarray expression analysis in blood identifies pathways linked to signs and symptoms of a patient with hypercalprotectinaemia and hyperzincaemiaH S Isaksson, S A Farkas, P Müller, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 1, 1993
A new rat model of arterial thrombosis with a platelet-rich head and an erythrocyte-rich tail: thrombolysis experiments with specific thrombin inhibitionS Lenfors, L Marberg, S Wikström, et al.
Journal of Thrombosis and Haemostasis : JTH|July 23, 2003
A randomized, controlled, dose-guiding study of the oral direct thrombin inhibitor ximelagatran compared with standard therapy for the treatment of acute deep vein thrombosis: THRIVE IH Eriksson, K Wåhlander, D Gustafsson, et al.
Blood Pressure|May 1, 1992
Raised plasma concentrations of endothelin-1 and -3 in marmosets with acute aortic stenosis: no relation to the renin-angiotensin systemD Gustafsson, M Elg, T Hedner, et al.
Nature Nanotechnology|December 11, 2012
Fully gapped superconductivity in a nanometre-size YBa2Cu3O(7-δ) island enhanced by a magnetic fieldD Gustafsson, D Golubev, M Fogelström, et al.
American Heart Journal|July 1, 1988
The role of sympathetic activity in atherogenesis: effects of beta-blockadeB Ablad, J A Björkman, D Gustafsson, et al.
Journal of Cardiovascular Pharmacology|March 26, 1998
Melagatran, an oral active-site inhibitor of thrombin, prevents or delays formation of electrically induced occlusive thrombus in the canine coronary arteryJ L Mehta, L Chen, W W Nichols, et al.
Ultrasound in Medicine & Biology|January 1, 1992
Noninvasive measurement of diameter changes in the distal abdominal aorta in manT Länne, H Stale, H Bengtsson, et al.
Pageof 6